MUSC Health only hospital in state to achieve national ranking by U.S. News & World Report
MUSC Health, the clinical enterprise of the Medical University of South Carolina (MUSC), is dedicated to the pursuit of changing what’s possible in health care. Nationally recognized for its innovation, patient- and family-centered care, and quality outcomes, this integrated health care system is accessible at the downtown Charleston campus and through more than 100 outreach locations, clinical affiliations with numerous health care partners, and a robust telehealth network. MUSC Health logs more than one million patient encounters annually, and its specialized care teams consistently rank among the best in the country. MUSC Health delivers transformational care shaped by world-class clinicians, health scientists, and educators who provide leading-edge care, while developing the next generation of innovative health care leaders.
Embolism Risk Study
MUSC leads massive nation-wide study to balance risks of pulmonary embolisms and excessive bleeding after hip and knee replacement.
The roots of the current opioid addiction epidemic are complex. MUSC is introducing novel models to combat the problem.
Predicting Adolescent Alcohol Consumption
Researchers hope to better pinpoint which teams would be likelier to abuse alcohol, so targeted interventions can be done.
Study of Brain Development
An ambitious long-term study of brain development and child health called ABCD is the largest study of this type in the nation.
Trauma & Brain Development
70% of children will experience some kind of traumatic event by the time they are 18. 50% percent will experience some form of interpersonal trauma.
Young patients with leukemia may be able to get a new type of treatment known as CAR T-cell immunotherapy at MUSC Health, possibly within a year.
A concussion detection aid developed at the Medical University of South Carolina may one day help with field sobriety testing and other applications.
A novel drug screen in liver-like cells shows promise for treating hypercholesterolemia.
Cancer surgeon & researcher Nancy DeMore, M.D., is leading a clinical trial using frankincense to try to treat breast & colon cancer.
Hollings Clinical Trials
Trials at the MUSC Hollings Cancer Center, an NCI-designated cancer center, run the gamut from phase 1 trials to translation.
TIL Therapy and Lung Cancer
A team of MUSC investigators is working develop a new treatment option for some patients with lung cancer: Tumor-infiltrating T lymphocyte — or TIL— therapy.
MUSC offers robotically assisted procedures in many areas, including the duodenal switch, mitral valve repair and now the DIEP flap.
Work Family Balance
Both women & men experience more depression during their internship year; yet female interns are more likely to suffer from symptoms of gender difference.